Self‐Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer

Self‐Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer

Abstract Chemoradiotherapy is the standard of care for the clinical treatment of locally advanced head and neck cancers. However, the combination of ion radiation with free chemotherapeutics yields unsatisfactory therapeutic output and severe side effects due to the nonspecific biodistribution of th...

Full description

Bibliographic Details
Main Authors:	Yun Zhu, Shunan Zhang, Yi Lai, Jiaxing Pan, Fangmin Chen, Tingting Wang, Fengyang Wang, Zhiai Xu, Wenjun Yang, Haijun Yu
Format:	Article
Language:	English
Published:	Wiley 2022-12-01
Series:	Advanced Science
Subjects:	chemoradiotherapy cooperative therapy head and neck cancer immune evasion immunogenic cell death
Online Access:	https://doi.org/10.1002/advs.202203263

Similar Items

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
by: Jiayi Ye, et al.
Published: (2022-06-01)

Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy
by: Gunjesh Kumar Singh, et al.
Published: (2017-03-01)

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
by: Jantien Hoek, et al.
Published: (2016-02-01)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
by: Yeona Cho, et al.
Published: (2018-10-01)

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
by: Hundo Cho, et al.
Published: (2022-05-01)

Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
by: Rhiannon Mellor, et al.
Published: (2024-02-01)

Patients with Spondylodiscitis following Chemoradiotherapy for Head and Neck Cancer in a Portuguese Cancer Hospital: A Case Report
by: Diana Pessoa, et al.
Published: (2024-04-01)

Evaluation of the Safety of Percutaneous Sensory Nerve Stimulation in Patients with Head and Neck Cancer Receiving Chemoradiotherapy
by: Takao Hamamoto, et al.
Published: (2023-07-01)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
by: Hayashi N, et al.
Published: (2021-11-01)

A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
by: Pei-Wei Huang, et al.
Published: (2018-04-01)

Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
by: Hiromichi Shirasu, et al.
Published: (2020-03-01)

Outcome in radiographic complete regression of unresectable head and neck cancer with carotid artery encasement from induction chemotherapy followed by concurrent chemoradiotherapy: Case reports
by: Federico Ampil, et al.
Published: (2019-06-01)

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
by: Juan L. Callejas-Valera, et al.
Published: (2022-05-01)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
by: Qiuji Wu, et al.
Published: (2021-10-01)

Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan
by: Aleksandra Kapała, et al.
Published: (2021-05-01)

Safety and efficacy of concurrent chemoradiotherapy for head-and-neck cancers in older versus younger patients: Post hoc analysis of a randomized controlled trial
by: Gunjesh Kumar Singh, et al.
Published: (2020-01-01)

Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
by: Francesca De Felice, et al.
Published: (2021-05-01)

Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication
by: Nafisha Lalani, et al.
Published: (2018-01-01)

L-Glutamine and Survival of Patients with Locally Advanced Head and Neck Cancer Receiving Chemoradiotherapy
by: Takae Tsujimoto, et al.
Published: (2023-09-01)

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer
by: Petr Szturz, et al.
Published: (2019-02-01)

Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
by: Wei Jiang, et al.
Published: (2022-03-01)

Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer
by: Łukasz Boguszewicz, et al.
Published: (2023-12-01)

On measuring tax evasion /
by: 237974 Elffers, Henk, et al.

Radiomic Analysis of Tumour Heterogeneity Using MRI in Head and Neck Cancer Following Chemoradiotherapy: A Feasibility Study
by: Amrita Guha, et al.
Published: (2022-02-01)

Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial
by: Camilla K. Lonkvist, et al.
Published: (2017-06-01)

Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial
by: Florence Legouté, et al.
Published: (2019-05-01)

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck
by: Tomohiro Enokida, et al.
Published: (2018-08-01)

Mechanisms of immune evasion by head and neck cancer stem cells
by: Flávia Caló Aquino Xavier, et al.
Published: (2022-08-01)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
by: Muhammad Shahid Iqbal, et al.
Published: (2017-04-01)

Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx
by: Hung-Ming Wang, et al.
Published: (2014-06-01)

Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial
by: Sadamoto Zenda, et al.
Published: (2018-09-01)

Role of postoperative chemoradiotherapy in head and neck cancer without positive margins or extracapsular extension: a propensity score-matching analysis
by: Zhi-Qiao Liu, et al.
Published: (2022-11-01)

Can zinc supplementation widen the gap between control and complications in head and neck cancer patients treated with concurrent chemo-radiotherapy
by: Mohsin Khan, et al.
Published: (2019-01-01)

Competing Morbidities In Advanced Head And Neck Squamous Cell Carcinoma Concurrent Chemoradiotherapy: A Strong Implication Of A Multidisciplinary Team Approach
by: Lazzari G, et al.
Published: (2019-11-01)

Detection of Cancer Recurrence Using Systemic Inflammatory Markers and Machine Learning after Concurrent Chemoradiotherapy for Head and Neck Cancers
by: Yoon Kyoung So, et al.
Published: (2023-07-01)

Nutritional status of patients undergoing concurrent chemoradiotherapy for malignant tumor and its influencing factors
by: WANG Peng, WANG Zheng, ZHANG Lichuan, WANG Yujie, LU Qian
Published: (2024-02-01)

Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
by: Yilmaz B, et al.
Published: (2021-10-01)

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary
by: Yazan Abu-Shama, et al.
Published: (2021-05-01)

Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision
by: Chao-Hung Wang, et al.
Published: (2022-06-01)

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy
by: David M. Vossen, et al.
Published: (2019-03-01)